Project Grant HT94252410026
Award Date
3/1/24
Completion Date
2/28/26
Dollars Obligated
$323K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency has awarded a $1,400,000 Project Grant to The Methodist Hospital Research Institute (HMRI) in Houston, Texas under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 15, 2024 through September 14, 2027, will support the "Development of a Novel Therapeutic to Treat DNA Damage Associated with Atypical Burns". This project will focus on advanced biomedical...
The Department of Defense's Defense Health Agency awarded a $444,125 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Methodist Hospital Research Institute (HMRI) in Houston, Texas. The grant, titled "IDENTIFICATION OF LIAX BINDING PARTNERS FOR PREVENTING RESISTANCE", will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on...
This federal Project Grant award, totaling $431,750.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will support research conducted by the University of Houston System to investigate the role of H19X noncoding RNAs in the pathogenesis of myotonic dystrophy type I. The award duration is from December 1, 2024 to November 30, 2026. The Military Medical Research and Development program funds advanced biomedical...
The Department of the Army Medical Command awarded The Methodist Hospital Research Institute $319,669 under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2021 through May 31, 2023. The project aims to investigate novel M2 lipogenic macrophages associated with fracture callus that are altered in type 2 diabetes. Baylor College of Medicine will serve as a sub-awardee to assist with the research. Through the support of basic, applied, and advanced...
The University of Houston received a $299,787 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project from May 1, 2023 to April 30, 2025 to evaluate the diagnostic utility of antibodies to histone post-translational modifications in pediatric lupus patients. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with...
The U.S. Defense Health Agency awarded a $777,659 Project Grant to the Children's Research Institute in Washington, D.C. under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to transform healthcare for military service members, veterans, and the public, with a focus on innovative research addressing critical health challenges. Specifically, the award will fund the "Use of ProResolution and Restorative Pharmacology...
The Defense Health Agency awarded a $974,043 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development (CFDA 12.420) program. The grant supports early cardiac biomarker research focused on inflammation and remodeling in Duchenne muscular dystrophy. This 4-year award, running from September 1, 2025 to August 31, 2029, will fund innovative biomedical investigations at Cedars-Sinai aimed at transforming healthcare for military service members and the broader...
The federal Project Grant award of $1,496,576.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at Baylor College of Medicine in Houston, Texas, aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational domains, will focus on innovative investigations across multiple medical...
The U.S. Defense Health Agency awarded a $662,742 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Methodist Hospital Research Institute (HMRI) in Houston, Texas. The grant supports a 3-year research study titled "Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury: A Hybrid Implementation-Efficacy Trial". The research aims to develop and evaluate an innovative home-based neuromodulation system to help manage...
This federal Project Grant award of $323,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Methodist Hospital Research Institute (HMRI) to target the METTL3 gene in order to overcome drug resistance in metastatic clear cell renal cell carcinoma. The award period runs from September 1, 2025 to August 31, 2029. HMRI is a prominent nonprofit medical research organization in Houston, Texas, known for its...